SEOM clinical guidelines for hereditary cancer

被引:14
|
作者
Grana, Begona [1 ,2 ]
Lastra, Enrique [3 ]
Llort, Gemma [4 ]
Brunet, Joan [5 ]
Isla, Dolores [6 ]
机构
[1] VHIO, Dept Med Oncol, High Risk & Canc Prevent Unit, ES-08035 Barcelona, Spain
[2] Marcide Hosp, Ferrol Healthcare Area, La Coruna, Spain
[3] Gen Yague Hosp, Med Oncol Sect, Genet Counselling Unit, Burgos, Spain
[4] Valles Inst Oncol, Genet Counselling Unit, Barcelona, Spain
[5] ICO, Hereditary Canc Program, Dept Med Oncol, Girona, Spain
[6] Lozano Blesa Hosp, Dept Med Oncol, Zaragoza, Spain
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2011年 / 13卷 / 08期
关键词
Hereditary cancer; BRCA1; BRCA2; Lynch syndrome; BRCA2 MUTATION CARRIERS; NONPOLYPOSIS COLORECTAL-CANCER; OVARIAN-CANCER; LYNCH-SYNDROME; BREAST-CANCER; SALPINGO-OOPHORECTOMY; INHERITED MUTATIONS; YOUNG-WOMEN; RISK; FAMILIES;
D O I
10.1007/s12094-011-0701-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Research in genetics has facilitated the identification of highly penetrant genes responsible for a large number of diseases. In the oncology field, genetic counselling and gene testing are focused on the two most common syndromes in familial cancer: hereditary breast and ovarian cancer syndrome (HBOC) and hereditary non-polyposis colorectal cancer or Lynch syndrome (LS). The objective of this guideline in hereditary cancer is to summarise the current state of knowledge and make recommendations in the areas of diagnosis, prevention and treatment of hereditary cancer.
引用
收藏
页码:580 / 586
页数:7
相关论文
共 50 条
  • [1] SEOM clinical guidelines for hereditary cancer
    Begoña Graña
    Enrique Lastra
    Gemma Llort
    Joan Brunet
    Dolores Isla
    Clinical and Translational Oncology, 2011, 13 : 580 - 586
  • [2] SEOM clinical guidelines in Hereditary Breast and ovarian cancer
    G. Llort
    I. Chirivella
    R. Morales
    R. Serrano
    A. Beatriz Sanchez
    A. Teulé
    E. Lastra
    J. Brunet
    J. Balmaña
    B. Graña
    Clinical and Translational Oncology, 2015, 17 : 956 - 961
  • [3] SEOM clinical guidelines in Hereditary Breast and ovarian cancer
    Llort, G.
    Chirivella, I.
    Morales, R.
    Serrano, R.
    Beatriz Sanchez, A.
    Teule, A.
    Lastra, E.
    Brunet, J.
    Balmana, J.
    Grana, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 956 - 961
  • [4] SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)
    Gonzalez-Santiago, S.
    Ramon y Cajal, T.
    Aguirre, E.
    Ales-Martinez, J. E.
    Andres, R.
    Balmana, J.
    Grana, B.
    Herrero, A.
    Llort, G.
    Gonzalez-del-Alba, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 193 - 200
  • [5] SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)
    S. González-Santiago
    T. Ramón y Cajal
    E. Aguirre
    J. E. Alés-Martínez
    R. Andrés
    J. Balmaña
    B. Graña
    A. Herrero
    G. Llort
    A. González-del-Alba
    Clinical and Translational Oncology, 2020, 22 : 193 - 200
  • [6] Thyroid cancer: SEOM clinical guidelines
    J. M. Trigo
    J. Capdevila
    E. Grande
    J. Grau
    P. Lianes
    Clinical and Translational Oncology, 2014, 16 : 1035 - 1042
  • [7] Thyroid cancer: SEOM clinical guidelines
    Trigo, J. M.
    Capdevila, J.
    Grande, E.
    Grau, J.
    Lianes, P.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (12): : 1035 - 1042
  • [8] Clinical guideline seom: hereditary colorectal cancer
    Guillen-Ponce, C.
    Serrano, R.
    Sanchez-Heras, A. B.
    Teule, A.
    Chirivella, I.
    Martin, T.
    Martinez, E.
    Morales, R.
    Robles, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 962 - 971
  • [9] Clinical guideline seom: hereditary colorectal cancer
    C. Guillén-Ponce
    R. Serrano
    A. B. Sánchez-Heras
    A. Teulé
    I. Chirivella
    T. Martín
    E. Martínez
    R. Morales
    L. Robles
    Clinical and Translational Oncology, 2015, 17 : 962 - 971
  • [10] SEOM clinical guidelines for the treatment of oesophageal cancer
    Gallego, Javier
    Cervantes, Andres
    Pericay, Carles
    Isla, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08): : 520 - 524